Haemonetics Corp Q3 FY2020 Earnings Call

Haemonetics Corp (HAE)

Earnings Call FY2020 Q3 Call date: 2020-02-04 Concluded

Quarter scorecard

Revenue

$258.97M

+4.7% YoY

Diluted EPS

$0.58

+65.7% YoY

Gross margin

49.4%

+4.5 pp YoY

Net income

$29.89M

+63.6% YoY

Plasma Products and Services $141.23M

+7.1%

Blood Center Products and Services $66.13M

-1.5%

Hospital Products and Services $51.61M

+6.7%